The Taiwan Food and Drug Administration (TFDA) on Tuesday announced a recall of over 1.78 million tablets of an antipsychotic medication due to cross-contamination from another pharmaceutical ingredient during the manufacturing process.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Media personality Lucifer Chu receives 11 months for indecent assault
11/14/2024 04:39 PM - Business
U.S. dollar closes higher on Taipei forex market
11/14/2024 04:21 PM - Politics
America First, containing China focuses of Trump's new gov't: NSB chief
11/14/2024 04:05 PM - Society
'Zombie drug' reclassified as Category 2 narcotic
11/14/2024 03:58 PM - Business
TSMC declines to comment on U.S. discriminatory hiring lawsuit
11/14/2024 03:32 PM